 |
 |

A Systematic Review of Autologous Transplantation Methods in Vitiligo
M. D. Njoo, MD;
W. Westerhof, MD, PhD;
J. D. Bos, MD, PhD;
P. M. M. Bossuyt, MD, PhD
Arch Dermatol. 1998;134:1543-1549.
Objective A systematic review of the effectiveness, safety, and applicability of autologous transplantation methods in vitiligo.
Data Sources Computerized searches of bibliographical databases, a complementary manual literature search, and contacts with researchers and pharmaceutical firms.
Study Selection Predefined selection criteria were applied to all studies found.
Data Extraction Two investigators independently assessed the articles for inclusion. When there was a disagreement, a third investigator was consulted.
Data Synthesis Sixty-three studies were found, of which 16 reported on minigrafting, 13 on split-thickness grafting, 15 on grafting of epidermal blisters, 17 on grafting of cultured melanocytes, and 2 on grafting of noncultured epidermal suspension. Of these, 39 patient series were included. The highest mean success rates (87%) were achieved with split-skin grafting (95% confidence interval, 82%-91%), and epidermal blister grafting (87%) (95% confidence interval, 83%-90%). The mean success rate of 5 culturing techniques varied from 13% to 53%. However, in 4 of the 5 culturing methods, fewer than 20 patients were studied. Minigrafting had the highest rates of adverse effects but was the easiest, fastest, and least expensive method.
Conclusions Because no controlled trials were included, treatment recommendations should be formulated with caution. Split-thickness and epidermal blister grafting can be recommended as the most effective and safest techniques. No definite conclusions can be drawn about the effectiveness of culturing techniques because only a small number of patients have been studied. The choice of method also depends on certain disease characteristics and the availability of specialized personnel and equipment.
From the Netherlands Institute for Pigmentary Disorders (Drs Njoo and Westerhof), and the Departments of Dermatology (Drs Westerhof and Bos) and Clinical Epidemiology and Biostatistics (Dr Bossuyt), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Vitiligo: To Treat or Not to Treat
Lim and Hexsel
Arch Dermatol 2007;143:643-646.
FULL TEXT
New Insights and New Therapies in Vitiligo
Grimes
JAMA 2005;293:730-735.
FULL TEXT
Erbium:YAG Laser and Cultured Epidermis in the Surgical Therapy of Stable Vitiligo
Guerra et al.
Arch Dermatol 2003;139:1303-1310.
ABSTRACT
| FULL TEXT
Childhood Vitiligo and Tacrolimus: Immunomodulating Treatment for an Autoimmune Disease
Plettenberg et al.
Arch Dermatol 2003;139:651-654.
FULL TEXT
Vitiligo: The Evolution of Cultured Epidermal Autografts and Other Surgical Treatment Modalities
Yaar and Gilchrest
Arch Dermatol 2001;137:348-349.
FULL TEXT
Treatment of "Stable" Vitiligo by Timedsurgery and Transplantation of Cultured Epidermal Autografts
Guerra et al.
Arch Dermatol 2000;136:1380-1389.
ABSTRACT
| FULL TEXT
The Development of Guidelines for the Treatment of Vitiligo
Njoo et al.
Arch Dermatol 1999;135:1514-1521.
ABSTRACT
| FULL TEXT
|